Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation
暂无分享,去创建一个
D. Niederwieser | U. Platzbecker | S. Schwind | V. Vucinic | M. Bill | D. Backhaus | Georg-Nikolaus Franke | Johannes Küpper | M. Jentzsch | J. Grimm | D. Brauer | Julia Schulz | V. Vučinić | G. Franke